Literature DB >> 20729953

Primary carcinosarcoma of the ear: case report and review of the literature.

Susun Bellew, James Q Del Rosso, Narciss Mobini.   

Abstract

Primary carcinosarcoma is a very rare neoplasm comprising two intermingling malignant components-epithelial and mesenchymal. The authors report a new case of primary cutaneous carcinosarcoma involving the helix of the ear. Immunohistochemical analysis revealed epithelial components of both basal cell and squamous cell carcinomas with a partially ossified sarcomatous-like component.Cutaneous carcinosarcoma (CS) is a neoplasm with dual epithelial and mesenchymal malignant components. It is most commonly seen in elderly males on sun-exposed areas of the body.(1-2) The histogenesis of CS is currently under debate. Immunohistochemistry plays an integral part in the diagnosis of this rare biphasic neoplasm. After a review of the literature, the authors were able to find only four other reported cases of CS involving the ear.(1,3) They present the fifth case of primary cutaneous CS, which involved the helix of the ear.

Entities:  

Year:  2009        PMID: 20729953      PMCID: PMC2923961     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  18 in total

1.  Cutaneous carcinosarcoma: report of a case with myofibroblastic sarcomatous component.

Authors:  Tommaso Agostini; Andrea Mori; Genny Leporatti; Mario Dini; Alessandro Franchi
Journal:  Dermatol Surg       Date:  2008-02-06       Impact factor: 3.398

2.  P63 is a helpful tool in the diagnosis of a primary cutaneous carcinosarcoma.

Authors:  Paolo Romanelli; Maria Miteva; Elissa Schwartzfarb; Carlos Ricotti; Tory Sullivan; Pascual Abenoza; Mehrdad Nadji
Journal:  J Cutan Pathol       Date:  2009-02       Impact factor: 1.587

Review 3.  Carcinosarcoma of skin.

Authors:  E J Leen; M P Saunders; D I Vollum; C E Keen
Journal:  Histopathology       Date:  1995-04       Impact factor: 5.087

4.  Carcinosarcoma of the skin: immunohistochemical and electron microscopic observations.

Authors:  S Izaki; A Hirai; Y Yoshizawa; K Kitamura; T Inoue; M Hatoko; S Itoyama; M Inazu
Journal:  J Cutan Pathol       Date:  1993-06       Impact factor: 1.587

5.  Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.

Authors:  Tien Anh Tran; Sigfrid Muller; Prakash J Chaudahri; J Andrew Carlson
Journal:  J Cutan Pathol       Date:  2005-01       Impact factor: 1.587

6.  Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.

Authors:  S Kounelis; M W Jones; H Papadaki; A Bakker; P Swalsky; S D Finkelstein
Journal:  Hum Pathol       Date:  1998-01       Impact factor: 3.466

7.  Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature.

Authors:  S M Bigby; A Charlton; M V Miller; L J Zwi; G F Oliver
Journal:  J Cutan Pathol       Date:  2005-02       Impact factor: 1.587

Review 8.  Primary carcinosarcoma of the skin: report of a case and review of the literature.

Authors:  T J Brown; J A Tschen
Journal:  Dermatol Surg       Date:  1999-06       Impact factor: 3.398

Review 9.  Primary metaplastic carcinoma (carcinosarcoma) of the skin. A clinicopathologic study of four cases and review of the literature.

Authors:  N K Patel; P H McKee; N P Smith; C D Fletcher
Journal:  Am J Dermatopathol       Date:  1997-08       Impact factor: 1.533

10.  Sarcomatoid carcinoma of the skin: report of a case.

Authors:  J J Ríos-Martín; J A Parra-Martín; A Gómez-Pascual; A Hevia-Vázquez; R González-Cámpora
Journal:  J Dermatol       Date:  1998-05       Impact factor: 4.005

View more
  1 in total

1.  Sarcomatoid carcinoma after radiotherapy for early-stage oral squamous cell carcinoma: Case report.

Authors:  Bo Young Kim; Kyoung Rai Cho; Jung Heob Sohn; Jung Yeon Kim
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.